Facile synthesis of metal-organic framework films via in situ seeding of nanoparticles

A facile in situ nanoparticle seeding method is reported to prepare MIL-101(Cr) films on alumina supports. The in situ seeding of MIL-101(Cr) nanoparticles was promoted by use of dimethylacetamide (DMA). The generality of this approach is further demonstrated for Cu(3)(btc)(2) films by using a (poly)acrylate promoter.     

螺旋波激发甲烷等离子体光谱诊断

利用螺旋波激发等离子体化学气相沉积(LPP-CVD)技术,以甲烷和氦气为反应气体产生等离子体.通过采集到甲烷的可见光到紫外发射光谱,对甲烷等离子体进行原位诊断,发现存在CH、Ha及Hβ等碎片粒子的光辐射,同时,分析了不同入射功率、气压下CH粒子以及Hβ、Hγ的相对强度变化情况.结果表明:CH粒子的相对强度随着射频功率是先增大而后减小,随工作气压的增大而逐渐减小;随气压及功率的增加,Hβ、Hγ相对强度变化的总体趋势都是先增加而后减小的.     

Sonochemical synthesis of Dy2(CO3)3 nanoparticles,Dy(OH)3 nanotubes and their conversion to Dy2O3 nanoparticles

Dysprosium carbonates nanoparticles were synthesized by the reaction of dysprosium acetate and NaHCO₃ by a sonochemical method. Dysprosium oxide nanoparticles with average size about 17 nm were prepared from calcination of Dy₂(CO₃)₃·1.7H₂O nanoparticles. Dy(OH)₃ nanotubes were synthesized by sonication of Dy(OAC)₃·6H₂O and N₂H₄. The as-synthesized nanostructures were characterized by scanning electron microscopy (SEM), X-ray powder diffraction (XRD), transmission electron microscopy (TEM), and Fourier transform infrared spectroscopy (FT-IR). Photoluminescence measurement shows that the nanoparticles have two emission peaks around 17,540 cm^?1 and 20,700 cm^?1, which should come from the electron transition from ⁴F_9/2 → ⁶H_15/2 levels and ⁴F_9/2 → ⁶H_13/2 levels, respectively. The effect of calcination temperature and sonication time was investigated on the morphology and particle size of the products. The sizes could be controlled by the feeding rate of the precipitating agent (NaHCO₃ and N₂H₄) and slower feeding rate lead to smaller nanoparticles.     

Guiding Drugs to Target‐Harboring Organelles: Stretching Drug‐Delivery to a Higher Level of Resolution

The ratio between the dose of drug required for optimal efficacy and the dose that causes toxicity is referred to as the therapeutic window. This ratio can be increased by directing the drug to the diseased tissue or pathogenic cell. For drugs targeting fungi and malignant cells, the therapeutic window can be further improved by increasing the resolution of drug delivery to the specific organelle that harbors the drug's target. Organelle targeting is challenging and is, therefore, an under‐exploited strategy. Here we provide an overview of recent advances in control of the subcellular distribution of small molecules with the focus on chemical modifications. Highlighted are recent examples of active and passive organelle‐specific targeting by incorporation of organelle‐directing molecular determinants or by chemical modifications of the pharmacophore. The outstanding potential that lies in the development of organelle‐specific drugs is becoming increasingly apparent.